CYGB and coinfection: Figure 1a shows no difference in the days of diagnosis before hospitalization, age, and BMI between the two groups. We found statistical differences in terms of days of hospitalization (p < 0.0001) and number of co-infections (p = 0.0032), which were both higher in ECMO_D compared to ECMO_S patients. Biochemical and hematological laboratory parameters, shown in Figure 1b, revealed that WBC, lymphocytes, neutrophils, NLR, PLT, RBC, HCT, and HGB levels were higher in both ECMO groups compared to the HC cohort, and no difference was observed between ECMO_S and ECMO_D patients.